EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M503. A total of 15 filers reported holding EYEGATE PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $534,000 | +907.5% | 237,477 | +1502.1% | 0.00% | – |
| Q2 2021 | $53,000 | -27.4% | 14,823 | 0.0% | 0.00% | – |
| Q1 2021 | $73,000 | +17.7% | 14,823 | +17.1% | 0.00% | – |
| Q4 2020 | $62,000 | -54.7% | 12,656 | -63.9% | 0.00% | – |
| Q3 2020 | $137,000 | -18.5% | 35,030 | +0.6% | 0.00% | – |
| Q2 2020 | $168,000 | -6.1% | 34,838 | +1.1% | 0.00% | – |
| Q1 2020 | $179,000 | -73.4% | 34,454 | -48.9% | 0.00% | – |
| Q4 2019 | $674,000 | – | 67,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sassicaia Capital Advisers LLC | 25,000 | $56,000 | 0.16% |
| Tuttle Capital Management, LLC | 18,174 | $41,000 | 0.05% |
| XTX Topco Ltd | 13,867 | $31,000 | 0.01% |
| Sterling Financial Planning, Inc. | 1,171 | $3,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 13,832 | $31,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,000 | $2,000 | 0.00% |
| JANE STREET GROUP, LLC | 34,742 | $78,000 | 0.00% |
| UBS Group AG | 399 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,468 | $3,000 | 0.00% |
| US BANCORP \DE\ | 2,710 | $6,000 | 0.00% |